Environmental Division |
|||
Session 560 - Regulation of Nanotechnology Product Sale and Use and Nano Toxicology – Nsef 22 | |||
This session seeks speakers who are involved in U.S. and non-U.S. product regulation development triggered by the growth of the nanotechnology industry, existing and/or proposed frameworks that will determine how the manufacture, use, and sale of nanomaterials or products containing nanomaterials will be regulated, as well as industrial approaches to commercialization of nanotechnology in the context of the developing regulatory environment, including EPA’s NanoMaterials Stewardship Program. | |||
Chair: | Mary Ellen Ternes | ||
CoChair: | Kurt Rindfusz | ||
560a | Overview of Nanotechnology Activities at EPA Under the Toxic Substances Control Act (TSCA) Jim Alwood |
||
560b | Nanotechnology: ChEmical and Toxicological Risk Assessments Issues with Antimicrobials Najm Shamin, Jenny Tao, Jonathan ChEn |
||
560c | Human Health Effects of Nanomaterials David A. Jones, Megan J. Winter |
||
560d | Classification of Engineered Nanoparticles According to Their Long Time Risk Potential for Human Health and Environment Wendelin J. Stark, Ludwig K. Limbach |
||
560e | Engineered Nanomaterial Interactions with Suspended Lipid Bilayers Steven A. Klein, Trevor J. Thornton, Jonathan D. Posner |
||
560f | In Vitro Toxicity Testing of CdTe Nanoparticles In Three-Dimensional Cell Culture Jungwoo Lee, G. Daniel Lilly, Nicholas A. Kotov |
See more of Environmental Division
See more of The 2008 Annual Meeting